Sign In

Bohai Pharmaceuticals Group Inc (OTC:BOPH)

Tuesday, January 12, 2010

Three Months Ended September 30,
	2009			2008

Sales	$	14,181,772		$	11,412,018

Less: Sales Tax		(227,168	)		(183,821	)

Net sales		13,954,604			11,228,197

Cost of sales		(2,217,604	)		(1,854,478	)

Gross profit		11,737,000			9,373,719

Selling, general and administrative expenses		(9,174,693	)		(6,651,539	)

Interest expenses		(148,395	)		(65,038	)

Operating income		2,413,912			2,657,142

Non-operating income		69,072			-

Non-operating costs		(5,269	)		(31	)

Income before taxes		2,477,715			2,657,111

Income taxes		(555,474	)		(600,199	)

Net income	$	1,922,241		$	2,056,912

________________________________________________________________________________________

Fiscal Year Ended June 30,
	2009			2008

Sales	$	50,170,014		$	38,172,513

Less: Sales Tax		(821,400	)		(629,489	)
Net sales		49,348,614			37,543,024

Cost of sales		(7,975,267	)		(5,950,680	)

Gross profit		41,373,347			31,592,344

Selling, general and administrative expenses		(31,301,811	)		(22,601,932	)

Interest expenses		(184,404	)		(234,101	)

Operating income		9,887,132			8,756,311

Non-operating income		49,447			8

Non-operating costs		(36,366	)		(835	)

Income before taxes		9,900,213			8,755,484

Income taxes		(1,906,985	)		(2,303,712	)

Net income	$	7,993,228		$	6,451,772

Using our post reverse merger share count of 27,912,500 yields a trailing EPS number of $0.29.